Trinucleotide repeat disorders

Feb 12, 2020

Global Bell's Palsy Incidence Assessment by Ethnicity & Geography, 2019-2029

Nov 07, 2019

Spinocerebellar Ataxia (SCA) Epidemiology Forecast to 2028: Assumptions and Rationale, Total Prevalent Population, Total Diagnosed Cases, Type-Specific Prevalence

Jul 31, 2019

REGENXBIO Announces New License Agreement with Pfizer for the Treatment of Friedreich's Ataxia Using NAV® AAV9 Vector

Jul 09, 2019

EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Huntington's Disease

Apr 05, 2019

Dystrogen Therapeutics Announces That Gene Therapy Successfully Cuts Off Production of Neuron-Destroying Protein in Huntington's Disease

Mar 14, 2019

Biohaven Enrolls First Patient In Phase 3 Spinocerebellar Ataxia Clinical Trial Of Troriluzole

Feb 05, 2018

Jupiter Orphan Therapeutics in Process to Submit IND for MPSI and Other Indications

Jun 27, 2017

Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies